Rising Menopausal Health Concerns Propel Global Menopausal Hot Flashes Market

October 20, 2023 04:45 PM BST | By EIN Presswire
 Rising Menopausal Health Concerns Propel Global Menopausal Hot Flashes Market
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, October 20, 2023 /EINPresswire.com/ -- The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

2027 Market Size Projection
Anticipated to hit $17.63 billion in 2027, the menopausal hot flashes market is expected to grow at a CAGR of 5.8%.

Government Initiatives for Women's Health Driving Market Expansion
Government initiatives targeting women's health during menopause are set to catalyze growth in the menopausal hot flashes medication market. These initiatives include funding for extensive studies on the menopausal transition and related ailments, as well as support for pharmacological, clinical, and epidemiological research. Efforts to promote overall health through risk factor analysis, prevention, and early detection of critical health conditions are also encompassed. For example, the Government of New South Wales allocated $40.3 million over four years (2022-2026) to establish 16 new programs dedicated to aiding women experiencing severe menopausal symptoms.

Uncover the market's potential –
https://www.thebusinessresearchcompany.com/sample.aspx?id=12592&type=smp

Innovative Product Offerings Transforming the Market Landscape
An emerging trend in the menopausal hot flashes market is the introduction of innovative products by leading companies. Astellas Pharma US Inc. announced the FDA approval of Veozah in May 2023, marking a significant milestone as the first neurokinin 3 (NK3) receptor inhibitor authorized for treating hot flashes associated with menopause.

Major Players Leading Market Advancements
Key players contributing to market advancements include Pfizer Inc., Johnson & Johnson, The Procter & Gamble Company, and several other notable pharmaceutical companies.

Region-Wise Analysis
In 2022, North America dominated the menopausal hot flashes market, while the Asia-Pacific region is expected to witness the most rapid growth during the forecast period. The report encompasses regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.

Market Segmentation:
Type: Hormonal Treatment, Non-hormonal Treatment, Alternative Treatment
Pipeline Analysis: Phase III Drugs, Phase I and II Drugs
Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies
Application: 51-55 Year Old Woman, 46-50 Year Old Woman, 40-45 Year Old Woman

Explore the comprehensive report –
https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Menopausal Hot Flashes Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Menopausal Hot Flashes Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on menopausal hot flashes market size, menopausal hot flashes market drivers and trends, menopausal hot flashes market major players, competitors' revenues, menopausal hot flashes market positioning, and menopausal hot flashes market growth across geographies. The menopausal hot flashes market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company?
Women’s Health Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Women’s Health Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report

Sanitary Paper Product Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/sanitary-paper-product-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next